These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 2576143)

  • 1. The effects of ondansetron (GR38032F) in rats and mice treated subchronically with diazepam.
    Costall B; Jones BJ; Kelly ME; Naylor RJ; Oakley NR; Onaivi ES; Tyers MB
    Pharmacol Biochem Behav; 1989 Dec; 34(4):769-78. PubMed ID: 2576143
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of the 5-HT3 antagonist GR38032F (ondansetron) on benzodiazepine withdrawal in rats.
    Goudie AJ; Leathley MJ
    Eur J Pharmacol; 1990 Aug; 185(2-3):179-86. PubMed ID: 1979273
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sites of action of ondansetron to inhibit withdrawal from drugs of abuse.
    Costall B; Jones BJ; Kelly ME; Naylor RJ; Onaivi ES; Tyers MB
    Pharmacol Biochem Behav; 1990 May; 36(1):97-104. PubMed ID: 2140900
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ondansetron inhibits a behavioural consequence of withdrawing from drugs of abuse.
    Costall B; Jones BJ; Kelly ME; Naylor RJ; Onaivi ES; Tyers MB
    Pharmacol Biochem Behav; 1990 Jun; 36(2):339-44. PubMed ID: 2141423
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Profile of action of a novel 5-hydroxytryptamine1A receptor ligand E-4424 to inhibit aversive behavior in the mouse, rat and marmoset.
    Costall B; Domeney AM; Farre AJ; Kelly ME; Martinez L; Naylor RJ
    J Pharmacol Exp Ther; 1992 Jul; 262(1):90-8. PubMed ID: 1352556
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of acute and chronic treatment of various serotonergic agents with those of diazepam and idazoxan in the rat elevated X-maze.
    Wright IK; Heaton M; Upton N; Marsden CA
    Psychopharmacology (Berl); 1992; 107(2-3):405-14. PubMed ID: 1352058
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The influence of 5-HT2 and 5-HT4 receptor antagonists to modify drug induced disinhibitory effects in the mouse light/dark test.
    Costall B; Naylor RJ
    Br J Pharmacol; 1997 Nov; 122(6):1105-18. PubMed ID: 9401775
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The anxiolytic effect of ondansetron and its capacity to eliminate the benzodiazepine abstinence syndrome in rats].
    Garibova TL; Voronina TA; Kraĭneva VA; Val'dman EA
    Eksp Klin Farmakol; 1999; 62(6):16-9. PubMed ID: 10650519
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The potential anxiolytic activity of GR38032F, a 5-HT3-receptor antagonist.
    Jones BJ; Costall B; Domeney AM; Kelly ME; Naylor RJ; Oakley NR; Tyers MB
    Br J Pharmacol; 1988 Apr; 93(4):985-93. PubMed ID: 2898961
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antianxiety profile of ondansetron, a selective 5-HT3 antagonist, in a novel animal model.
    Roychoudhury M; Kulkarni SK
    Methods Find Exp Clin Pharmacol; 1997 Mar; 19(2):107-11. PubMed ID: 9151286
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Level of punishment determines anticonflict activity of ondansetron in pigeons: comparison with buspirone and diazepam.
    Castejón AM; Cubeddu LX
    Pharmacol Biochem Behav; 1998 Dec; 61(4):451-7. PubMed ID: 9802841
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of DN-2327, a new anxiolytic, diazepam and buspirone on exploratory activity of the rat in an elevated plus-maze.
    Wada T; Fukuda N
    Psychopharmacology (Berl); 1991; 104(4):444-50. PubMed ID: 1685794
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diazepam withdrawal-induced anxiety and place aversion in the rat: differential effects of two chronic diazepam treatment regimes.
    Allison C; Claase LA; Pratt JA
    Behav Pharmacol; 2002 Sep; 13(5-6):417-25. PubMed ID: 12394418
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lack of withdrawal signs of dependence following cessation of treatment or Ro-15,1788 administration to rats chronically treated with buspirone.
    Eison MS
    Neuropsychobiology; 1986; 16(1):15-8. PubMed ID: 3106850
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of serotonergic anxiolytics on physical dependence on diazepam in mice.
    Mizoguchi H; Suzuki T; Misawa M
    Neurosci Lett; 1993 Sep; 160(1):41-4. PubMed ID: 7902543
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Conflicting evidence regarding the efficacy of ondansetron in benzodiazepine withdrawal.
    Prather PL; Rezazadeh SM; Lane JD; Rowan GA; Hooper ML; Lytle DA; Emmett-Oglesby MW; Lal H
    J Pharmacol Exp Ther; 1993 Feb; 264(2):622-30. PubMed ID: 8094750
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The benzodiazepines: anxiolytic and withdrawal effects.
    Little HJ
    Neuropeptides; 1991 Jul; 19 Suppl():11-4. PubMed ID: 1679209
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anxiolytic effects of CCK-B antagonists.
    Costall B; Domeney AM; Hughes J; Kelly ME; Naylor RJ; Woodruff GN
    Neuropeptides; 1991 Jul; 19 Suppl():65-73. PubMed ID: 1679211
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Flumazenil prevents the anxiolytic effects of diazepam, alprazolam and adinazolam on the early acquisition of two-way active avoidance.
    Escorihuela RM; Fernández-Teruel A; Zapata A; Núñez JF; Tobeña A
    Pharmacol Res; 1993; 28(1):53-8. PubMed ID: 8234145
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effects of umespirone as a potential anxiolytic and antipsychotic agent.
    Barnes NM; Costall B; Domeney AM; Gerrard PA; Kelly ME; Krähling H; Naylor RJ; Tomkins DM; Williams TJ
    Pharmacol Biochem Behav; 1991 Sep; 40(1):89-96. PubMed ID: 1685786
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.